Crestone Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $288K | Sell |
|
|||||
|
2023
Q3 | $676K | Sell |
|
|||||
|
2023
Q2 | $1.24M | Sell |
|
|||||
|
2023
Q1 | $1.14M | Sell |
|
|||||
|
2022
Q4 | $1.8M | Sell |
|
|||||
|
2022
Q3 | $2.68M | Sell |
|
|||||
|
2022
Q2 | $6.05M | Buy |
|
|||||
|
2022
Q1 | $6.35M | Buy |
|
|||||
|
2021
Q4 | $870K | Sell |
|
|||||
|
2021
Q3 | $1.13M | Sell |
|
|||||
|
2021
Q2 | $1.54M | Sell |
|
|||||
|
2021
Q1 | $2.19M | Sell |
|
|||||
|
2020
Q4 | $2.32M | Sell |
|
|||||
|
2020
Q3 | $2.56M | Sell |
|
|||||
|
2020
Q2 | $3.51M | Sell |
|
|||||
|
2020
Q1 | $4.1M | Sell |
|
|||||
|
2019
Q4 | $5.37M | Sell |
|
|||||
|
2019
Q3 | $4.39M | Buy |
|
|||||
|
2019
Q2 | $4.82M | Buy |
|
|||||
|
2019
Q1 | $3.23M | Buy |
|
|||||
|
2018
Q4 | $2.2M | Sell |
|
|||||
|
2018
Q3 | $2.96M | Buy |
|
|||||
|
2018
Q2 | $1.07M | Buy |
|